BF.B
31
2
AAL
48
6
ABBV
57
-2
CINF
37
6
SYY
44
-8
WBA
48
-2
NWL
54
-2
O
35
5
BXP
47
3
ZBH
59
2
NVDA
54
2
FOXA
59
7
HIG
52
2
A
47
6
BLK
66
2
SBUX
36
-3
CAH
44
-6
AMAT
40
-3
WAT
66
2
MTCH
50
19
BF.B
31
2
AAL
48
6
ABBV
57
-2
CINF
37
6
SYY
44
-8
WBA
48
-2
NWL
54
-2
O
35
5
BXP
47
3
ZBH
59
2
NVDA
54
2
FOXA
59
7
HIG
52
2
A
47
6
BLK
66
2
SBUX
36
-3
CAH
44
-6
AMAT
40
-3
WAT
66
2
MTCH
50
19
Financhill
Back

Teva Pharmaceutical Industries Quote, Financials, Valuation and Earnings

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!
Buy
57

TEVA
Teva Pharmaceutical Industries

Last Price:
18.78
Seasonality Move:
12.65%

7 Day Trial

ALL ACCESS PASS

$ 7

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade

Teva Pharmaceutical Industries Price Quote

$18.78
+0.14 (+0.75%)
(Updated: November 5, 2024 at 4:15 PM ET)

Teva Pharmaceutical Industries Key Stats

Buy
57
Teva Pharmaceutical Industries (TEVA) is a Buy
Day range:
$18.38 - $18.80
52-week range:
$8.55 - $19.08
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.29
P/B ratio:
3.32%
Volume:
7.1M
Avg. volume:
5.4M
1-year change:
107.34%
Market cap:
$21.1B
Revenue:
$15.8B
EPS:
$-0.39

How Much Does Teva Pharmaceutical Industries Make?

Is Teva Pharmaceutical Industries Growing As A Company?

Teva Pharmaceutical Industries Stock Price Performance

What Is Teva Pharmaceutical Industries 52-Week High & Low?

Teva Pharmaceutical Industries Price To Free Cash Flow

Is It Risky To Buy Teva Pharmaceutical Industries?

Is Teva Pharmaceutical Industries Cash Flow Positive?

Teva Pharmaceutical Industries Return On Invested Capital

  • Is Management Doing A Good Job?
    TEVA return on invested capital is -1.75%
  • What Is Teva Pharmaceutical Industries Return On Assets?
    ROA measures how assets are converting to revenues and is -1.12%
  • What Is TEVA Return On Equity?
    ROE is a measure of profitability and is -6.36%

Teva Pharmaceutical Industries Earnings Date & Stock Price

Teva Pharmaceutical Industries Competitors

Teva Pharmaceutical Industries Dividend Yield

Teva Pharmaceutical Industries Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -6.69%
Revenue: 7.4% 2.12%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 21.81
Upside from Last Price: 17%

Major Shareholders

  • How many TEVA shares are owned by institutional investors?
    843M TEVA shares are owned by institutional investors
  • How many TEVA shares are owned by insiders?
    6.4M TEVA shares are owned by insiders